Germantown, MD · Founded 2019 · Privately Held (backing)
Operator of a biotechnology company intended to develop and deliver life-changing medicines for cancer and inflammatory diseases. DEKA Biosciences is based in Germantown, MD and was founded in 2019. It was valued at $36 million at its early-stage round in Feb 2023, the last priced event on record. It has raised $104 million across 2 recorded rounds; the latest was a $29.9 million early-stage round in Feb 2023.
PMV mark · valuation
$36.0M
Oct 2026
Priced at
its early-stage round
Feb 2023
Total raised
$104.2M
Last round
Early Stage VC
Feb 2023
Cap table — not yet on record
DEKA Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of DEKA Biosciences with a free account
·Watch DEKA Biosciences: the Monday email on marks, rounds and moves
Where does DEKA Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across DEKA Biosciences's 2 recorded funding rounds.
